Exhibit 10.16
ALIGOS THERAPEUTICS, INC.
CHANGE IN CONTROL AND SEVERANCE AGREEMENT
This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Matthew McClure (“Executive”) and Aligos Therapeutics, Inc. (the “Company”), effective as of December 1, 2020 (the “Effective Date”).
Background
Agreement
The parties hereto agree as follows:
(Signature page follows)
The parties have executed this Agreement, in the case of the Company by its duly authorized officer, as of the dates set forth below.
ALIGOS THERAPEUTICS, INC.
By:
Title:
Date:
EXECUTIVE
Matthew McClure
Date: